95 results
8-K/A
EX-10.1
NEO
Neogenomics Inc.
18 Jul 22
Departure of Directors or Certain Officers
4:31pm
beyond normal retirement, under the Equality Act 2010 or the Employment Equality (Age) Regulations 2006;
(x)for direct or indirect discrimination
8-K
qrjohsvfga
11 May 22
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
5:02pm
8-K
EX-99.1
4pv8 joe5154
14 Apr 22
Other Events
4:23pm
8-K
EX-10.1
4ud5hywkvzmlr
28 Mar 22
NeoGenomics Announces CEO Departure and Initiates CEO Search
4:20pm
8-K
EX-99.1
yc7q1i3i52966hqu 6y
23 Feb 22
NeoGenomics Reports Full Year Revenue of $484 Million and Fourth Quarter Results
7:14am
8-K
EX-99.1
v9ppj 2b6y
4 Nov 21
NeoGenomics Reports Revenue of $121 Million
7:23am
8-K
EX-99.1
ppgdi vlk
12 Oct 21
NeoGenomics Announces Board of Directors’ Transition
5:03pm
8-K
blbz0qzwys9vomw045n
12 Oct 21
NeoGenomics Announces Board of Directors’ Transition
5:03pm
8-K
EX-99.1
2q3yvb3
10 Aug 21
Regulation FD Disclosure
5:09pm
8-K
EX-99.1
znm288
6 Aug 21
NeoGenomics Reports 40% Revenue Growth to $122 Million
7:10am